HSA
CBIO

HBK Sorce Advisory’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

HBK Sorce Advisory’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-117
Closed -$2.92K – 602
2024
Q4 		$2.92K Buy
+117
New +$2.92K ﹤0.01% 574